Today, Canadian clinical-stage biotech company Cardiol Therapeutics (NASDAQ:CRDL) is seeing impressive investor interest although the biotech firm closed down about 2%. However, CRDL stock has been a big mover in the past few months, nearly doubling since the beginning of August. Source: Shutterstock The company’s focus is on research and development around anti-inflammatory drugs for cardiovascular…

Investing trends come and go, and some emerge and begin to stick for investors on and off Wall Street. From the peak of the r/WallStreetBets subreddit community earlier this year to new communities of investors discussing stocks today, these groups continue to change the way investing is performed. That said, one trend that continues to…